Siplizumab selectively depletes effector memory T cells and promotes a relative expansion of alloreactive regulatory T cells in vitro

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (S10RR027050, S10OD020056, P30CA013696, 5P30DK063608)

This publication has 44 references indexed in Scilit: